The Global Fund, Cervical Cancer, and HPV infections: what can low- and middle-income countries do to accelerate progress by 2030?
- PMID: 40083441
- PMCID: PMC11905856
- DOI: 10.1016/j.eclinm.2025.103127
The Global Fund, Cervical Cancer, and HPV infections: what can low- and middle-income countries do to accelerate progress by 2030?
Abstract
The footprint of cervical cancer mirrors the impact of global inequity and inequality on the right to health for girls and women. While today, cervical cancer is a relatively rare cause of death in Europe, North America, and Australia, almost 94% of deaths in 2022 occurred in low- and middle-income countries (LMICs). Governments adopted the WHO global strategy to eliminate cervical cancer. Still, the stark reality is that many countries may not reach the 90:70:90 targets by 2030 without political commitment and a sense of urgency. We call for enhanced advocacy for the right to prevention services and political actions to mobilise global funding, local philanthropic support, and innovative financing. During the COVID-19 pandemic, an African coalition raised over $20 million to mitigate the impact of the pandemic. Positive lessons from this response should be replicated to save millions of women and girls at risk of cervical cancer in LMICs. There is a need for a global fund for cancer; regional blocs like the African Union need to recognise the disproportionate burden and establish continental funding mechanisms to enable high-burden countries to make crucial upfront health systems investments that will put their countries on the pathway to cervical cancer elimination.
Funding: This study was not funded.
Keywords: Cervical cancer elimination; Global fund for cancer; Global inequity; HPV; Meeting global targets; Patient engagement; Prevention.
© 2025 Published by Elsevier Ltd.
Conflict of interest statement
RCWC declared Roche Product Ltd grant to Project PINK BLUE—Health & Psychological Trust Centre for community intervention.
Figures
References
-
- Bray F., Laversanne M., Sung H., et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21834 [cited 2024 Nov 22]. Available from: - DOI - PubMed
-
- World Health Organization . World Health Organization; Geneva, Switzerland: 2020. Global strategy to accelerate the elimination of cervical cancer as a public health problem.https://iris.who.int/bitstream/handle/10665/336583/9789240014107-eng.pdf... Available from:
-
- Knaul F.M., Rodriguez N.M., Arreola-Ornelas H., Olson J.R. Cervical cancer: lessons learned from neglected tropical diseases. Lancet Glob Health. 2019;7(3):e299–e300. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X%2818%293... [cited 2023 Dec 10]; Available from: - PubMed
-
- International agency for research on cancer. Cervix uteri. World Health Organization; Lyon, France: 2024. pp. 1–2.https://gco.iarc.who.int/media/globocan/factsheets/cancers/23-cervix-ute... Available from:
-
- de Martel C., Plummer M., Vignat J., Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–670. https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.30716 [cited 2024 Nov 22]; Available from: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
